158 related articles for article (PubMed ID: 30386121)
21. A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.
Carrión JA; Gonzalez-Colominas E; García-Retortillo M; Cañete N; Cirera I; Coll S; Giménez MD; Márquez C; Martin-Escudero V; Castellví P; Navinés R; Castaño JR; Galeras JA; Salas E; Bory F; Martín-Santos R; Solà R
J Hepatol; 2013 Nov; 59(5):926-33. PubMed ID: 23811030
[TBL] [Abstract][Full Text] [Related]
22. Cryoglobulinemia in chronic hepatitis C: clinical aspects and response to treatment with interferon alpha and ribavirin.
Parise ER; de Oliveira AC; Ferraz ML; Pereira AB; Leite KR
Rev Inst Med Trop Sao Paulo; 2007; 49(2):67-72. PubMed ID: 17505661
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia.
Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A
Pharmacogenet Genomics; 2016 Jun; 26(6):307-10. PubMed ID: 27139837
[TBL] [Abstract][Full Text] [Related]
24. Introduction of direct-acting antiviral agents alters frequencies of anti-GPIIb/IIIa antibody-producing B cells in chronic hepatitis C patients with thrombocytopenia.
Satoh T; Uojima H; Wada N; Takiguchi H; Kaneko M; Nakamura M; Gonda N; Homma M; Hidaka H; Kusano C; Horie R
Platelets; 2023 Dec; 34(1):2161498. PubMed ID: 36597279
[TBL] [Abstract][Full Text] [Related]
25. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients.
Baur K; Mertens JC; Schmitt J; Iwata R; Stieger B; Frei P; Seifert B; Bischoff Ferrari HA; von Eckardstein A; Müllhaupt B; Geier A;
Antivir Ther; 2012; 17(3):541-7. PubMed ID: 22300961
[TBL] [Abstract][Full Text] [Related]
26. Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors.
Gragnani L; Piluso A; Giannini C; Caini P; Fognani E; Monti M; Petrarca A; Ranieri J; Razzolini G; Froio V; Laffi G; Zignego AL
Arthritis Rheum; 2011 May; 63(5):1446-51. PubMed ID: 21538321
[TBL] [Abstract][Full Text] [Related]
27. Increased baseline proinflammatory cytokine production in chronic hepatitis C patients with rapid virological response to peginterferon plus ribavirin.
Par G; Szereday L; Berki T; Palinkas L; Halasz M; Miseta A; Hegedus G; Szekeres-Bartho J; Vincze A; Hunyady B; Par A
PLoS One; 2013; 8(7):e67770. PubMed ID: 23874444
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin treatment.
Elefsiniotis IS; Vezali E; Kamposioras K; Pantazis KD; Tontorova R; Ketikoglou I; Moulakakis A; Saroglou G
World J Gastroenterol; 2006 Jul; 12(27):4420-4. PubMed ID: 16865790
[TBL] [Abstract][Full Text] [Related]
29. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin.
Atsukawa M; Tsubota A; Shimada N; Yoshizawa K; Abe H; Asano T; Ohkubo Y; Araki M; Ikegami T; Okubo T; Kondo C; Osada Y; Nakatsuka K; Chuganji Y; Matsuzaki Y; Iwakiri K; Aizawa Y
Hepatol Res; 2016 Mar; 46(5):450-8. PubMed ID: 26289410
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.
Atsukawa M; Tsubota A; Shimada N; Kondo C; Itokawa N; Nakagawa A; Hashimoto S; Fukuda T; Matsushita Y; Kidokoro H; Narahara Y; Nakatsuka K; Iwakiri K; Kawamoto C; Sakamoto C
Hepat Mon; 2013; 13(12):e14872. PubMed ID: 24403915
[TBL] [Abstract][Full Text] [Related]
31. Interactive Impacts from Hepatitis C Virus Infection and Mixed Cryoglobulinemia on Complement Levels.
Chang ML; Hu JH; Chen WT; Lin MS; Kuo CJ; Chen SC; Chien RN
Dig Dis Sci; 2021 Jul; 66(7):2407-2416. PubMed ID: 32737636
[TBL] [Abstract][Full Text] [Related]
32. Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(3):e0120794. PubMed ID: 25790297
[TBL] [Abstract][Full Text] [Related]
33. Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/ribavirin-based therapy in Egyptian patients with chronic hepatitis C.
Abdelsalam A; Rashed L; Salman T; Hammad L; Sabry D
J Dig Dis; 2016 Aug; 17(8):547-553. PubMed ID: 27128845
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?
Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH
World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970
[TBL] [Abstract][Full Text] [Related]
35. Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C.
Hung CH; Hu TH; Lu SN; Chen CH; Wang JH; Lee CM
J Formos Med Assoc; 2016 Apr; 115(4):278-83. PubMed ID: 26725771
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia.
Antonelli A; Ferri C; Ferrari SM; Ghiri E; Goglia F; Pampana A; Bruschi F; Fallahi P
Arthritis Rheum; 2009 Dec; 60(12):3841-7. PubMed ID: 19950277
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells.
Zhang J; Liu K; Zhang G; Ling N; Chen M
Virol J; 2022 Feb; 19(1):28. PubMed ID: 35144643
[TBL] [Abstract][Full Text] [Related]
38. Association Between Vitamin D Levels and Treatment Response to Direct-Acting Antivirals in Chronic Hepatitis C: A Real-World Study.
Gayam V; Mandal AK; Khalid M; Mukhtar O; Gill A; Garlapati P; Tiongson B; Sherigar J; Mansour M; Mohanty S
Gastroenterology Res; 2018 Aug; 11(4):309-316. PubMed ID: 30116431
[TBL] [Abstract][Full Text] [Related]
39. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.
Diago M; Castellano G; García-Samaniego J; Pérez C; Fernández I; Romero M; Iacono OL; García-Monzón C
Gut; 2006 Mar; 55(3):374-9. PubMed ID: 16150856
[TBL] [Abstract][Full Text] [Related]
40. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
Gragnani L; Fognani E; Piluso A; Boldrini B; Urraro T; Fabbrizzi A; Stasi C; Ranieri J; Monti M; Arena U; Iannacone C; Laffi G; Zignego AL;
Hepatology; 2015 Apr; 61(4):1145-53. PubMed ID: 25431357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]